A University of Queensland start-up company, developing a potential new treatment for obesity-related liver disease, has secured a seed investment of $1.3 million from IP...
Chronic inflammatory liver disease: cell stress mechanisms identified as prognostic factor: PSC is a rare disease with a poor prognosis and can lead to cirrhosis...
Chronic inflammatory liver disease: lipid-metabolism enzyme a potential factor in new treatment approach: Primary sclerosing cholangitis (PSC) is a rare, chronic, inflammatory disease of the...